Provided by Tiger Trade Technology Pte. Ltd.

NovaBay Pharmaceuticals

14.08
+4.6248.86%
Volume:3.92M
Turnover:51.56M
Market Cap:1.77B
PE:30.18
High:14.75
Open:9.80
Low:9.69
Close:9.46
52wk High:14.75
52wk Low:0.4600
Shares:126.01M
Float Shares:4.98M
Volume Ratio:5.26
T/O Rate:78.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4666
EPS(LYR):-2.5347
ROE:-516.26%
ROA:-86.98%
PB:-661.39
PE(LYR):-5.56

Loading ...

NovaBay Pharmaceuticals Reports Turnaround in Earnings

TIPRANKS
·
Nov 14, 2025

NovaBay Pharmaceuticals Inc. Files Initial Beneficial Ownership Statement for CEO and Director Michael Kazley

Reuters
·
Oct 21, 2025

NovaBay Pharmaceuticals, Inc. Regains Compliance With Nyse American Continued Listing Standards

THOMSON REUTERS
·
Oct 21, 2025

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

GlobeNewswire
·
Oct 21, 2025

NovaBay Pharmaceuticals - on Oct 16, Michael Kazley Appointed as CEO and Chairman - SEC Filing

THOMSON REUTERS
·
Oct 20, 2025

NovaBay Pharmaceuticals Sells Preferred Shares and Pre-Funded Warrants Totaling $18 Million

Reuters
·
Oct 20, 2025

NovaBay Pharmaceuticals Inc - David Lazar Resigns as CEO - SEC Filing

THOMSON REUTERS
·
Oct 10, 2025

NovaBay Pharmaceuticals announces resignation of CEO David Lazar and transfer of preferred stock to new investors

Reuters
·
Oct 10, 2025

BRIEF-NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing

Reuters
·
Oct 04, 2025

NovaBay files $200M mixed securities shelf

TIPRANKS
·
Oct 04, 2025

NovaBay Pharmaceuticals Inc. Announces Date for Annual Stockholders Meeting

Reuters
·
Sep 24, 2025

Press Release: NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

Dow Jones
·
Sep 19, 2025

NovaBay Pharmaceuticals Inc. Announces Date for 2025 Annual Stockholders Meeting

Reuters
·
Sep 11, 2025

Top Midday Gainers

MT Newswires Live
·
Aug 28, 2025

NovaBay Pharmaceuticals Declares Special Cash Dividend of $0.80 a Share, Payable Sept. 29 to Holders of Record Sept. 15

MT Newswires Live
·
Aug 27, 2025

David Lazar Reports 19.99% Stake in NovaBay Pharmaceuticals Inc as of August 19 - SEC Filing

THOMSON REUTERS
·
Aug 27, 2025

David Lazar Says Purchased NovaBay Pharmaceuticals Shares Based on Belief That Shares, When Purchased, "Undervalued"

THOMSON REUTERS
·
Aug 27, 2025

Press Release: NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

Dow Jones
·
Aug 27, 2025

NovaBay Pharmaceuticals Inc - Expects to Declare Special Cash Dividend in Q3 2025

THOMSON REUTERS
·
Aug 20, 2025

NovaBay Pharmaceuticals Inc - David E. Lazar Appointed as NovaBay's CEO and Director

THOMSON REUTERS
·
Aug 20, 2025